Brii Biosciences Limited (BRII-B, stock code 02137) has notified the market that its board of directors will convene on 19 March 2026.
The meeting’s agenda includes: 1. Reviewing and approving the audited annual results for the financial year ended 31 December 2025. 2. Authorising the publication of the FY 2025 results announcement. 3. Handling other routine corporate matters.
The board currently comprises two executive directors—Dr. Zhi Hong (Chairman) and Dr. Ankang Li—and five independent non-executive directors: Dr. Martin J Murphy Jr, Ms. Grace Hui Tang, Mr. Yiu Wa Alec Tsui, Mr. Gregg Huber Alton and Dr. Taiyin Yang.
The notice was released in Hong Kong on 9 March 2026 and was signed by Chairman Dr. Zhi Hong on behalf of the board.
Comments